IMUNON BIO
Dead / Abandoned — Abandoned — failure to respond (as of 17 Jan 2023)
What this means for you
This application is over — abandoned 03 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97036166
- Mark type
- Stylized text
- Filed
- 20 Sept 2021
- Abandoned
- 03 Jan 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals; Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations; biological preparations; vaccines; pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for use in immunotherapy; therapeutic agents for promotion of cancer immunity
- Class 042 — Scientific and technological services: Development of platform technology; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; bioinformatics, chemical and biological analysis; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, vaccination, and oncology
Owner
- Celsion Corporation, Lawrenceville, NJ, US
Prosecution history
- 17 Jan 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 17 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 17 Jan 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 01 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Jul 2022 — NON-FINAL ACTION E-MAILED
- 01 Jul 2022 — NON-FINAL ACTION WRITTEN
- 22 Jun 2022 — ASSIGNED TO EXAMINER
- 24 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Sept 2021 — NEW APPLICATION ENTERED